Get the Stockscreener App
0.6351
2.27%
0.0141
After Hours:
.63
-0.0051
-0.80%
Calcimedica Inc stock is traded at $0.6351, with a volume of 129.52K.
It is up +2.27% in the last 24 hours and down -23.48% over the past month.
CalciMedica Inc is a clinical-stage biopharmaceutical company focused on developing therapeutics that treat serious illnesses driven by inflammatory and immunologic processes and direct cellular damage. Its product candidates act upon calcium release-activated calcium (CRAC) channels and would constitute a new class of drugs. Its product candidate is Auxora, a potent and selective intravenous formulated small molecule CRAC channel inhibitor containing the active compound zegocractin (formerly referred to as CM4620) that, in animal models, reduced acute epithelial and/or endothelial cell injury and inflammation in organs, such as the pancreas, lungs and kidneys. The company operates as one operating segment focused on developing and commercializing therapeutics in the U.S.
See More
Previous Close:
$0.621
Open:
$0.62
24h Volume:
129.52K
Relative Volume:
0.11
Market Cap:
$10.00M
Revenue:
-
Net Income/Loss:
$-29.56M
P/E Ratio:
-0.3226
EPS:
-1.9688
Net Cash Flow:
$-21.21M
1W Performance:
+1.94%
1M Performance:
-23.48%
6M Performance:
-79.77%
1Y Performance:
-60.31%
1-Day Range:
$0.6056
$0.6425
1-Week Range:
$0.6056
$0.6999
52-Week Range:
$0.4606
$7.20
Calcimedica Inc Stock (CALC) Company Profile
Name
Calcimedica Inc
Sector
Industry
Phone
858-952-5500
Address
505 COAST BOULEVARD SOUTH, LA JOLLA
Compare CALC vs VRTX, REGN, ARGX, ALNY, ONC
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
CALC
Calcimedica Inc
|
0.6351 | 9.78M | 0 | -29.56M | -21.21M | -1.9688 |
VRTX
Vertex Pharmaceuticals Inc
|
441.70 | 113.01B | 12.07B | 3.95B | 3.19B | 15.33 |
REGN
Regeneron Pharmaceuticals Inc
|
753.93 | 79.87B | 14.34B | 4.50B | 3.77B | 41.56 |
ARGX
Argen X Se Adr
|
840.87 | 51.51B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
333.39 | 45.29B | 3.71B | 313.75M | 465.38M | 2.2571 |
ONC
Beone Medicines Ltd Adr
|
319.94 | 34.41B | 5.36B | 287.73M | 924.18M | 2.5229 |
Calcimedica Inc Stock (CALC) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-29-26 | Downgrade | H.C. Wainwright | Buy → Neutral |
Calcimedica Inc Stock (CALC) Latest News
CALC Options Chain — NASDAQ:CALC - TradingView — Track All Markets
MACD Signal: Does CalciMedica Inc outperform in volatile marketsMarket Sentiment Report & AI Enhanced Trading Alerts - baoquankhu1.vn
Profit Review: Does CalciMedica Inc have consistent dividend growth2026 Growth vs Value & Accurate Technical Buy Alerts - baoquankhu1.vn
EPS Watch: Is CalciMedica Inc attractive for institutional investorsPortfolio Gains Summary & Real-Time Volume Analysis Alerts - baoquankhu1.vn
Jobs Data: Is CalciMedica Inc exposed to currency risks2026 PostEarnings & Free High Accuracy Swing Entry Alerts - baoquankhu1.vn
CalciMedica (NASDAQ: CALC) grants CSO 65,124 options at $0.585 - Stock Titan
CalciMedica (CALC) awards CBO 83,358 stock options at $0.585 - Stock Titan
CalciMedica (CALC) grants 65,124 stock options to President and COO - Stock Titan
Earnings Risk: Does CalciMedica Inc meet Warren Buffetts criteriaMarket Growth Review & Fast Momentum Entry Tips - baoquankhu1.vn
CALC PE Ratio & Valuation, Is CALC Overvalued - Intellectia AI
CALC Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
CalciMedica (CALC) price target decreased by 24.39% to 10.54 - MSN
If You Invested $1,000 in CALCIMEDICA INC (CALC) - Stock Titan
Revenue Check: Does CalciMedica Inc meet Warren Buffetts criteria2026 Drop Watch & Detailed Earnings Play Alerts - baoquankhu1.vn
Big Picture: Does CalciMedica Inc meet Warren Buffetts criteriaShare Buyback & Weekly Chart Analysis and Trade Guides - baoquankhu1.vn
CalciMedica receives Nasdaq delisting notices for market value and bid price - Investing.com Australia
CalciMedica Receives Nasdaq Deficiency Notices on Listing Standards - TipRanks
CalciMedica Disclosed Failure to Satisfy a Continued Listing Rule or Standard - TradingView
CalciMedica (NASDAQ: CALC) faces Nasdaq market value and $1 bid price breaches - Stock Titan
Analysis Recap: Can CalciMedica Inc outperform in the next rally2026 News Drivers & Fast Entry High Yield Stock Tips - baoquankhu1.vn
US Market Recap: Is CalciMedica Inc stock a smart retirement pick2026 Price Momentum & Daily Price Action Insights - baoquankhu1.vn
Latest CALC NewsCalciMedica Reports Second Quarter 2023 Fin... - Stock Titan
[EFFECT] CalciMedica, Inc. SEC Filing - Stock Titan
Analysts’ Top Healthcare Picks: Dianthus Therapeutics (DNTH), CalciMedica (CALC) - The Globe and Mail
Oppenheimer Cuts CalciMedica (NASDAQ:CALC) Price Target to $10.00 - Defense World
Aug Highlights: Can CalciMedica Inc outperform in the next rally2025 Top Gainers & Consistent Profit Trading Strategies - baoquankhu1.vn
Performance Recap: Should I set a stop loss on CalciMedica Inc2025 Momentum Check & Safe Entry Point Identification - baoquankhu1.vn
CalciMedica, Inc. Common Stock share price - livemint.com
CalciMedica (CALC) Receives Updated Analyst Rating from Oppenhei - GuruFocus
Oppenheimer Adjusts CalciMedica Price Target to $10 From $20, Maintains Outperform Rating - marketscreener.com
CalciMedica price target lowered to $10 from $20 at Oppenheimer - TipRanks
CALC Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Analysts’ Opinions Are Mixed on These Healthcare Stocks: CalciMedica (CALC) and Talphera (TLPH) - The Globe and Mail
Calcimedica Inc files for mixed shelf of up to $125 millionSEC filing - marketscreener.com
Calcimedica Inc Files For Mixed Shelf Of Up To $125 MillionSEC Filing - TradingView
CalciMedica (NASDAQ: CALC) files shelf to offer up to $125M in securities - Stock Titan
CalciMedica, Inc. Reports Earnings Results for the Full Year Ended December 31, 2025 - marketscreener.com
CalciMedica (NASDAQ: CALC) outlines Auxora pipeline, halted AKI trial and going concern risk - Stock Titan
12 Health Care Stocks Moving In Tuesday's Intraday Session - Benzinga
CalciMedica (Nasdaq: CALC) widens 2025 loss while advancing Auxora and PAH candidate - Stock Titan
CalciMedica Reports 2025 Financial Results and Provides Clinical Updates - PR Newswire
CalciMedica, Inc. Auditor Raises 'Going Concern' Doubt - marketscreener.com
Retail Trends: Whats next for CalciMedica Inc stock2025 Sector Review & Technical Entry and Exit Tips - baoquankhu1.vn
CALC Stock News Today | Earnings, Events & Price Alerts - Intellectia AI
CALC SEC FilingsCALCIMEDICA INC 10-K, 10-Q, 8-K Forms - Stock Titan
Jobs Data: Is Vistagen Therapeutics Inc. stock a top pick in earnings seasonGold Moves & Reliable Intraday Trade Alerts - baoquankhu1.vn
Does CalciMedica Inc. meet Warren Buffett’s criteria2025 Stock Rankings & Weekly High Conviction Ideas - mfd.ru
CALC Should I Buy - Intellectia AI
Should I set a stop loss on CalciMedica Inc.July 2025 Momentum & Weekly Watchlist for Consistent Profits - mfd.ru
Aug Highlights: What’s the fair value of DUK.PRA stockQuarterly Trade Review & Free Real-Time Market Sentiment Alerts - baoquankhu1.vn
12 Health Care Stocks Moving In Friday's After-Market Session - Benzinga
Calcimedica Inc Stock (CALC) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.69%
0.25%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):